BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27

• Pharm Country

  CanBiotech Will Showcase A Novel Diagnostic And Prognostic Test For Diffuse, Large B-Cell Lymphoma (DLBCL) At The American Society of Hematology Annual Meeting In New Orleans

  November 25, 2013

   · 

  1 min read
• ProSensa Holding N.V. And Partners Awarded Second European Consortium FP7 Research Grant

  November 25, 2013

   · 

  1 min read
• Drug Development

  Ventrus Biosciences, Inc. Completes Enrollment Of Second Pivotal Phase 3 Trial Of Diltiazem Cream (VEN 307) In Patients With Anal Fissure

  November 25, 2013

   · 

  1 min read
• Business

  Caliber Imaging & Diagnostics Appoints Robert P. Fischmann As VP Of Operations, A Newly Created Position

  November 25, 2013

   · 

  1 min read
• Drug Development

  Cyclacel Pharmaceuticals, Inc. Announces Data Safety Monitoring Board Recommendation To Continue The SEAMLESS Phase 3 Trial Of Sapacitabine In AML

  November 25, 2013

   · 

  1 min read
• Drug Development

  Boehringer Ingelheim Corporation Release: Pradaxa® (Dabigatran Etexilate) 150mg Bid Continues To Be The Only Oral Anticoagulant Which Showed Superior Ischaemic Stroke Reduction Vs. Warfarin In Its Pivotal Study RE-LY®

  November 25, 2013

   · 

  1 min read
• Lone Star Bio

  Seno Medical Instruments, Inc. Launches Pivotal Study Of New Functional Imaging Platform In Breast Cancer Diagnosis

  November 25, 2013

   · 

  3 min read
• Biotech Bay

  SI-BONE, Inc. Minimally Invasive Sacroiliac Joint Fusion Could Save Medicare An Estimated $660 Million

  November 25, 2013

   · 

  7 min read
• CHMP Recommends Otsuka Pharmaceutical Co., Ltd.'s Deltyba™ (Delamanid) For EU Approval For Treatment Of Multidrug-Resistant Tuberculosis (MDR-TB) In Combination With Optimized Background Regimen (OBR)

  November 25, 2013

   · 

  1 min read
• Policy

  Hematogenix Laboratory Services LLC - The First Diagnostic Testing And CLIA-Certified Biomarker Services Laboratory To Offer Advanced Cell Diagnostics, Inc., RNAscope® Assays To Clients

  November 25, 2013

   · 

  3 min read